European Companies Search Engine

Quick Search Power Search
Tips & Tricks
Our help pages Using the Quick Search and Power Search Overview explain how to use our search engine.

Vertex Pharmaceuticals (Europe) Ltd., London

Watch

If you put a company on your watch list, we'll notify you on your email address when there are new publications regarding this company.

This feature is only available to our premium service subscribers.

Learn more about the North Data Premium Service

Dossier

The dossier is a printable PDF file, summarizing information and publications for this company. The creation of dossiers is included in your subscription. After the creation of the dossier is completed, it will be sent to your email address .

Add to dossier (if available):

This feature is only available to our premium service subscribers.

Learn more about the North Data Premium Service

Name

Vertex Pharmaceuticals (Europe) Ltd.
Intercede 1083 Ltd.

Register

Chp
Companies House 02907620
Nocom
The Brønnøysund Register Centre 915140009
Sirul
Siren 423772409
Sirul
Siret 42377240900011

Address

2 Kingdom Street, London W2 6BD, United Kingdom
160 Aldersgate Street London, United Kingdom
Abingdon, United Kingdom

Corporate purpose

Wholesale business with pharmaceuticals.

Additional info

46.46
Wholesale of pharmaceutical goods

Financials

Earnings Revenue Employees

Earnings

For this company, Earnings numbers are only available to our premium service subscribers.

Learn more about the North Data Premium Service

Revenue

For this company, Revenue numbers are only available to our premium service subscribers.

Learn more about the North Data Premium Service

Employees

For this company, Employees numbers are only available to our premium service subscribers.

Learn more about the North Data Premium Service

History

Legal Representatives

Network

Loading network
CSV export

Quarterly Exports in CSV

Now available in CSV format and optimized for applications in AI and Analytics:
North Data's quarterly exports have become the industry standard for company information.

Publications

31 May 2024
No longer Nominee Secretary: Mitre Secretaries Ltd
26 Mar 2024 also 06/04/2023, 11/03/2022, 13/03/2019, 13/03/2018
Confirmation statement made with no updates
26 Jan 2024 via Vertex Pharmaceuticals (Poland) sp. z o.o., also 08/12/2017
Shareholding: Vertex Pharmaceuticals (Poland) sp. z o.o
30 Oct 2023 also 28/09/2022, 30/09/2021, 11/06/2020, 23/09/2019, 02/10/2018, 19/09/2017, 15/02/2017, 31/12/2015, 20/08/2014, 03/10/2013, 05/11/2012, 09/06/2011, 23/08/2010, 11/08/2009, 15/07/2008, 25/10/2007, 12/10/2006, 16/09/2005
Full accounts made up to 2022-12-31
16 Aug 2023
Patent: Administration of Deuterated Cftr Potentiators
1 Jun 2023 in France
Segment clas­si­fi­ca­tion
8 Feb 2022
Director: Jonathan Oppenheim
1 Jan 2022 in France
Name: VERTEX PHARMACEUTICALS (EUROPE) LIMITED
6 Dec 2021
No longer Director: Klas A. Holmlund
23 Mar 2021 also 11/03/2020, 14/03/2017
Confirmation statement made with updates
12 May 2020
Resolution of allotment of securities
6 May 2020 also 26/02/2015
Statement of capital following an allotment of shares
4 Sept 2019
Patent: Deuterated Derivatives of Ivacaftor
26 Apr 2019
Director: Ashley A. Grist, Klas A. Holmlund · No longer Director: Michele Bellandi, Ian Frederick Smith
16 Oct 2018
Director: Michele Bellandi · No longer Director: Simon Bedson
27 Apr 2017
Patent: Methods of Treatment with Deuterated Cftr Potentiators
22 Mar 2017
Patent: Deuterated Derivatives of Ivacaftor
10 Feb 2017
Patent: Deuterium-Modified Cftr Modulators
1 Jan 2017 in Hor
EU funding: Translational quantitative systems toxicology to improve the understanding of the safety of medicines - Sofia: 116030
Year 2016 in Epobase
4 European patent filings: Deuterated Cftr Potentiators …
11 Mar 2016
Capital: £128,000
8 Oct 2015
Director: Simon Bedson, Simon Kempin Lem · No longer Director: Jeffrey Marc Leiden
24 Jul 2015
Address
2 Jul 2015
Address
29 May 2015 via Vertex Pharmaceuticals (CH) LLC
Reg­is­tra­tion · Managing Director: Simon David Bedson · Chair of the board (1) · Shareholder: Vertex Pharmaceuticals (Europe) Ltd. · Address · Company statute
15 Apr 2015 via Vertex Pharmaceuticals GmbH
Shareholding: Vertex Pharmaceuticals GmbH
12 Mar 2015
Capital: £128,000
13 Mar 2014
Capital: £125,000
12 Mar 2013 also 13/03/2012
Annual return made up to 2013-03-11 with full list of shareholders
21 Jan 2013
Address
25 May 2012
Director: Jeffrey Marc Leiden
24 May 2012
No longer Director (1)
14 Oct 2011
Director (1)
13 Oct 2011
Director: Ian Frederick Smith · No longer Director (2)
17 Mar 2011
Director's details changed for Doctor Julian Marian Charles Golec · Annual return made up to 2011-03-11 with full list …
29 Jul 2010
No longer Director (1)
3 Jun 2010
Director's details changed for Dr Roger William Brimblecombe
6 Apr 2010
Address
1 Apr 2010
Address
16 Apr 2009 also 11/04/2008, 21/04/2007, 05/04/2006
Return made up to 11/03/09; full list of members
13 Jan 2009
No longer Director: Ian Frederick Smith
1 Jan 2008 as Vertex Pharmaceuticals Ltd. in France
Segment clas­si­fi­ca­tion
6 Dec 2007
Amended full accounts made up to 2006-12-31
7 Jun 2006 also 18/03/2005
Director resigned
20 Dec 2005 also 13/04/2005
New director appointed
7 Nov 2005
Auditor's resignation
2 Jun 2005
Return made up to 11/03/05; full list of members; amend · Director's particulars changed
5 May 2005
Return made up to 11/03/05; full list of members · Director's particulars changed
1 Apr 1999 as Vertex Pharmaceuticals Ltd. in France
Reg­is­tra­tion: 01/04/1999 · Address · Legal form: Société étrangère non immatriculée au RCS · Name: VERTEX PHARMACEUTICALS LTD

Mentions

24 Apr 2024 via Vertex Pharmaceuticals (Czech Republic) s.r.o.
Shareholder: Vertex Pharmaceuticals (Czech Republic) s.r.o
12 Oct 2022 via Vertex Pharmaceuticals (CH) LLC
Shareholding: Vertex Pharmaceuticals (CH) LLC
10 May 2021 via Vertex Pharmaceuticals (U.K.) Ltd.
Shareholding, Voting rights, Beneficial Owner: Vertex Pharmaceuticals (U.K.) Ltd

The data on this page is generated by a fully automated algorithm. It may have errors, and is provided on an "as is" basis with no guarantees of completeness, accuracy, usefulness or timeliness.

Creative Commons License The visualizations for "Vertex Pharmaceuticals (Europe) Ltd., London" are provided by North Data and may be reused under the terms of the Creative Commons CC-BY license.

Printing is only available to North Data premium service subscribers.
Close